Urine Arsenic and Hypertension in US Adults: the 2003-2008 National Health and Nutrition Examination Survey

Overview

Journal Epidemiology

Specialty Public Health

Date 2011 Jan 6

PMID 21206367

Citations 31

Authors

Miranda R Jones

Maria Tellez-Plaza

A Richey Sharrett

Eliseo Guallar

Ana Navas-Acien

Affiliations

Soon will be listed here.

Abstract

Background: High chronic exposure to inorganic arsenic may contribute to the development of hypertension. Limited information is available, however, on the association of low to moderate exposure to inorganic arsenic with blood pressure levels and hypertension. We investigated the association of exposure to inorganic arsenic (as measured in urine) with systolic and diastolic blood pressure levels and the prevalence of hypertension in US adults.

Methods: We studied 4167 adults 20 years of age or older who participated in the National Health and Nutrition Examination Survey (NHANES) from 2003 through 2008 and for whom total arsenic, dimethylarsinate (DMA), and arsenobetaine had been assessed in urine.

Results: The median (interquartile range) urine concentrations were 8.3 μg/L (4.2-17.1) for total arsenic, 3.6 μg/L (2.0-6.0) for DMA, and 1.4 μg/L (0.3-6.3) for arsenobetaine. The weighted prevalence of hypertension in the study population was 36%. After multivariable adjustment, a 2-fold increase in total arsenic was associated with a hypertension odds ratio of 0.98 (95% confidence interval = 0.86-1.11). A doubling of total arsenic minus arsenobetaine was associated with a hypertension OR of 1.03 (0.94-1.14) and a doubling of DMA concentrations was associated with a hypertension OR of 1.11 (0.99-1.24). Total arsenic, total arsenic minus arsenobetaine, or DMA levels were not associated with systolic or diastolic blood pressure.

Conclusions: At the low to moderate levels, typical of the US population, total arsenic, total arsenic minus arsenobetaine, and DMA concentrations in urine were not associated with the prevalence of hypertension or with systolic or diastolic blood pressure levels. A weak association of DMA with hypertension could not be ruled out.

Citing Articles

Arsenic Exposure-Related Hypertension in Bangladesh and Reduced Circulating Nitric Oxide Bioavailability.

Khatun M, Haque N, Siddique A, Wahed A, Islam M, Khan S Environ Health Perspect. 2024; 132(4):47003.

PMID: 38573329 PMC: 10993991. DOI: 10.1289/EHP13018.

Linking the Low-Density Lipoprotein-Cholesterol (LDL) Level to Arsenic Acid, Dimethylarsinic, and Monomethylarsonic: Results from a National Population-Based Study from the NHANES, 2003-2020.

Qu C, Huang R Nutrients. 2022; 14(19).

PMID: 36235646 PMC: 9573665. DOI: 10.3390/nu14193993.

Association of albumin to creatinine ratio with urinary arsenic and metal exposure: evidence from NHANES 2015-2016.

Rahman H, Niemann D, Munson-McGee S Int Urol Nephrol. 2021; 54(6):1343-1353.

PMID: 34643861 DOI: 10.1007/s11255-021-03018-y.

An atlas of metallome and metabolome interactions and associations with incident diabetes in the Strong Heart Family Study.

Sanchez T, Hu X, Zhao J, Tran V, LoIacono N, Go Y Environ Int. 2021; 157:106810.

PMID: 34365318 PMC: 8490308. DOI: 10.1016/j.envint.2021.106810.

Urinary Heavy Metals and Longitudinal Changes in Blood Pressure in Midlife Women: The Study of Women's Health Across the Nation.

Wang X, Karvonen-Gutierrez C, Herman W, Mukherjee B, Harlow S, Park S Hypertension. 2021; 78(2):543-551.

PMID: 34148361 PMC: 8266752. DOI: 10.1161/HYPERTENSIONAHA.121.17295.

References

Jensen G, Hansen M . Occupational arsenic exposure and glycosylated haemoglobin. Analyst. 1998; 123(1):77-80. DOI: 10.1039/a705699k. View

Navas-Acien A, Silbergeld E, Pastor-Barriuso R, Guallar E . Rejoinder: Arsenic exposure and prevalence of type 2 diabetes: updated findings from the National Health Nutrition and Examination Survey, 2003-2006. Epidemiology. 2009; 20(6):816-20. PMC: 2956265. DOI: 10.1097/EDE.0b013e3181afef88. View

Ahsan H, Perrin M, Rahman A, Parvez F, Stute M, Zheng Y . Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh. J Occup Environ Med. 2000; 42(12):1195-201. DOI: 10.1097/00043764-200012000-00016. View

Huang Y, Tseng C, Huang Y, Yang M, Chen C, Hsueh Y . Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol Appl Pharmacol. 2006; 218(2):135-42. DOI: 10.1016/j.taap.2006.10.022. View

Calderon R, Hudgens E, Le X, Schreinemachers D, Thomas D . Excretion of arsenic in urine as a function of exposure to arsenic in drinking water. Environ Health Perspect. 1999; 107(8):663-7. PMC: 1566491. DOI: 10.1289/ehp.99107663. View

Zierold K, Knobeloch L, Anderson H . Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water. Am J Public Health. 2004; 94(11):1936-7. PMC: 1448563. DOI: 10.2105/ajph.94.11.1936. View

Caldwell K, Jones R, Verdon C, Jarrett J, Caudill S, Osterloh J . Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003-2004. J Expo Sci Environ Epidemiol. 2008; 19(1):59-68. DOI: 10.1038/jes.2008.32. View

Barchowsky A, Roussel R, Klei L, James P, Ganju N, Smith K . Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxicol Appl Pharmacol. 1999; 159(1):65-75. DOI: 10.1006/taap.1999.8723. View

Karagas M, Le C, Morris S, Blum J, Lu X, Spate V . Markers of low level arsenic exposure for evaluating human cancer risks in a US population. Int J Occup Med Environ Health. 2001; 14(2):171-5. View

10.

Pi J, Kumagai Y, Sun G, Yamauchi H, Yoshida T, Iso H . Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic Biol Med. 2000; 28(7):1137-42. DOI: 10.1016/s0891-5849(00)00209-4. View

11.

Chen C, Hsueh Y, Lai M, Shyu M, Chen S, Wu M . Increased prevalence of hypertension and long-term arsenic exposure. Hypertension. 1995; 25(1):53-60. View

12.

Wang S, Chang F, Liou S, Wang H, Li W, Hsieh D . Inorganic arsenic exposure and its relation to metabolic syndrome in an industrial area of Taiwan. Environ Int. 2007; 33(6):805-11. DOI: 10.1016/j.envint.2007.03.004. View

13.

Sohel N, Persson L, Rahman M, Streatfield P, Yunus M, Ekstrom E . Arsenic in drinking water and adult mortality: a population-based cohort study in rural Bangladesh. Epidemiology. 2009; 20(6):824-30. DOI: 10.1097/EDE.0b013e3181bb56ec. View

14.

Carmignani M, Boscolo P, Castellino N . Metabolic fate and cardiovascular effects of arsenic in rats and rabbits chronically exposed to trivalent and pentavalent arsenic. Arch Toxicol Suppl. 1985; 8:452-5. DOI: 10.1007/978-3-642-69928-3_103. View

15.

Navas-Acien A, Francesconi K, Silbergeld E, Guallar E . Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population. Environ Res. 2010; 111(1):110-8. PMC: 3073506. DOI: 10.1016/j.envres.2010.10.009. View

16.

Lee M, Jung B, Chung S, Bae O, Lee J, Park J . Arsenic-induced dysfunction in relaxation of blood vessels. Environ Health Perspect. 2003; 111(4):513-7. PMC: 1241437. DOI: 10.1289/ehp.5916. View

17.

Steinmaus C, Yuan Y, Smith A . The temporal stability of arsenic concentrations in well water in western Nevada. Environ Res. 2005; 99(2):164-8. DOI: 10.1016/j.envres.2004.10.003. View

18.

Kwok R, Mendola P, Liu Z, Savitz D, Heiss G, Ling H . Drinking water arsenic exposure and blood pressure in healthy women of reproductive age in Inner Mongolia, China. Toxicol Appl Pharmacol. 2007; 222(3):337-43. DOI: 10.1016/j.taap.2007.04.003. View

19.

Hughes M . Biomarkers of exposure: a case study with inorganic arsenic. Environ Health Perspect. 2006; 114(11):1790-6. PMC: 1665401. DOI: 10.1289/ehp.9058. View

20.

Lewis D, Southwick J, Rench J, Calderon R . Drinking water arsenic in Utah: A cohort mortality study. Environ Health Perspect. 1999; 107(5):359-65. PMC: 1566417. DOI: 10.1289/ehp.99107359. View